Tianjin Ringpu Bio Tech (300119) — Cash Flow Reinvestment Rate
Tianjin Ringpu Bio Tech (300119) has a Cash Flow Reinvestment Rate of 0.22x as of September 2025, reinvesting CN¥23.24 Million (capex CN¥23.24 Million ) from operating cash flow of CN¥105.02 Million. Explore Tianjin Ringpu Bio Tech capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tianjin Ringpu Bio Tech Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Tianjin Ringpu Bio Tech across 19 annual periods. Also explore Tianjin Ringpu Bio Tech assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Tianjin Ringpu Bio Tech (2007–2025)
Year-by-year capital reinvestment analysis for Tianjin Ringpu Bio Tech. For live market cap and broader valuation context, see Tianjin Ringpu Bio Tech market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.79x | CN¥531.63 Million | CN¥297.53 Million | CN¥176.10 Million | ▲ +429.0% |
| 2024 | 0.34x | CN¥248.44 Million | CN¥735.55 Million | CN¥185.34 Million | ▼ -68.5% |
| 2023 | 1.07x | CN¥405.46 Million | CN¥378.20 Million | CN¥244.48 Million | ▼ -74.2% |
| 2022 | 4.15x | CN¥1.62 Billion | CN¥389.49 Million | CN¥372.43 Million | ▲ +142.5% |
| 2021 | 1.71x | CN¥655.02 Million | CN¥382.63 Million | CN¥305.88 Million | ▲ +148.8% |
| 2020 | 0.69x | CN¥267.23 Million | CN¥388.44 Million | CN¥259.17 Million | ▼ -37.0% |
| 2019 | 1.09x | CN¥418.70 Million | CN¥383.61 Million | CN¥229.70 Million | ▲ +17.2% |
| 2018 | 0.93x | CN¥162.91 Million | CN¥174.88 Million | CN¥112.45 Million | ▼ -29.9% |
| 2017 | 1.33x | CN¥142.90 Million | CN¥107.57 Million | CN¥108.87 Million | ▼ -52.3% |
| 2016 | 2.78x | CN¥578.12 Million | CN¥207.67 Million | CN¥128.13 Million | ▲ +35.3% |
| 2015 | 2.06x | CN¥463.56 Million | CN¥225.27 Million | CN¥151.10 Million | ▲ +44.3% |
| 2014 | 1.43x | CN¥183.11 Million | CN¥128.37 Million | CN¥183.11 Million | ▼ -49.7% |
| 2013 | 2.84x | CN¥251.60 Million | CN¥88.68 Million | CN¥251.60 Million | ▲ +52.4% |
| 2012 | 1.86x | CN¥167.37 Million | CN¥89.92 Million | CN¥167.37 Million | ▼ -9.1% |
| 2011 | 2.05x | CN¥184.82 Million | CN¥90.29 Million | CN¥184.82 Million | ▲ +383.2% |
| 2010 | 0.42x | CN¥47.79 Million | CN¥112.82 Million | CN¥47.79 Million | ▼ -12.7% |
| 2009 | 0.49x | CN¥31.34 Million | CN¥64.59 Million | CN¥31.34 Million | ▲ +68.0% |
| 2008 | 0.29x | CN¥19.66 Million | CN¥68.07 Million | CN¥19.66 Million | ▼ -67.5% |
| 2007 | 0.89x | CN¥16.99 Million | CN¥19.15 Million | CN¥16.99 Million | — |